NCT00696865View on ClinicalTrials.gov

AZD2624 Multiple Ascending Dose Study in Japan

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

May 31, 2008

Study Completion Date

August 31, 2008

Conditions

HealthySafety

Interventions

DRUG

AZD2624

oral suspension, 3 doses

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Kanagawa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY